ArticleMolecular genetics and metabolism reports2022

Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzyme.

Andreas Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.